Sex hormones have been proposed as a possible risk factor for the development and growth
of meningiomas. Hormonal therapy plays a fundamental role in the treatment of male‐to …

The role of sex hormones in the pathogenesis of meningioma is an area of ongoing
investigation. Here we describe the third published case of a de novo World Health …

Transsexualism is defined as a strong conviction of belonging to the opposite sex in
individuals without any physical intersex condition. Cross-sex hormone therapy is an …

Transsexual patients are routinely treated with sex hormone therapy, which may be a risk
factor for meningiomas, although the data are largely inconclusive. Here we describe a male …

Growth of a Meningioma in a Transsexual Patient after Estrogenâ•fiProgestin Therapy Page 1
correspondence n engl j med 357;23 www.nejm.org december 6, 2007 2411 Dr. Farooki …

Background: Gender-affirming hormone therapy is critical to the management of transgender
persons. Cyproterone acetate (CPA) is a synthetic, progesterone-like compound commonly …

Benign brain tumours may be hormone sensitive. To induce physical characteristics of the
desired gender, transgender individuals often receive cross-sex hormone treatment …

The administration of cyproterone acetate (CPA) and estradiol is a common regimen used
by male-to-female transsexuals (transwoman) to adjust their body to their gender identity …

Purpose Molecular and clinical observations suggest a role of sex steroid hormones in the
occurrence of meningioma. However, there is limited and often conflicting data on the use of …

Purpose Meningiomas are more common in females and 70–80% express the progesterone
receptor, raising the possibility that highdose exogenous estrogen/progesterone exposure …